Last Updated on 6^thFebruary 1999

• NPPA has notified the ceiling prices for some packs of the following formulations on 5th February 1999

      Explanatory note

  1. Dexamethasone Sodium + Gentamycin E / E (Drops)
  2. Verapamil HCL Inj.
  3. Cephazolin Sodium Inj.
  4. Chlorpromazine Inj.
  5. Spironolactone + Frusemide Tab.
     
• Non-Ceiling Prices of some Scheduled formulations of the following companies were fixed
  
  1. M/s Novo Nordisk Pharma (I) Ltd.
  2. M/s Biological E. Ltd.
  3. M/s Roussel India Ltd.
  4. M/s Wockhardt Ltd.
  5. M/s The Anglo French Drugs & Industries Ltd.
  6. M/s E. Merck (I) Ltd.
  7. M/s Nicholas Piramal (I) Ltd.

• NPPA has notified the ceiling prices for some packs of the following formulations on 1st December 1998
  
  1. Levodopa and Carbidopa Tablets
  2. Gentamycin E/E drops
  3. Suspension of Trimehoprim and Sulphamethoxazole

• Retail prices of some Scheduled formulations of the following companies were fixed
  
  1. Sanofi Torrent (India) Ltd.
  2. Roussel India Ltd.
  3. Nicholas Piramal (India) Ltd.
  4. East India Pharm Works Ltd.
  5. E. Merck (India) Ltd.
  6. Themis Chemicals Ltd.
  7. Kanpha Lab.
  8. Pharmacia & Upjohn India Pvt. Ltd.

Dr. P.V. Appaji
Deputy Director (Tech.)